Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

  • Read more about A Study to Evaluate Safety & Immunogenicity of SARS-CoV-2 DNA Vaccine Delivered Intramuscularly Followed by Electroporation for COVID-19

Variants of SARS-CoV-2 Causing COVID-19 in Africa

  • Read more about Variants of SARS-CoV-2 Causing COVID-19 in Africa

Adaptive Immune Response to COVID-19 Vaccination

  • Read more about Adaptive Immune Response to COVID-19 Vaccination

Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

  • Read more about Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

  • Read more about An Open-label, Clinical Feasibility Study of the Efficacy of Remdesivir for Long-COVID.

SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

  • Read more about SARS-CoV-2 Antibody Response in Children Aged 5-11 Years Following Vaccination Against COVID-19

Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

  • Read more about Immunogenicity and Safety Study of SARS-CoV-2 DNA Vaccine (ICCOV)

A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

  • Read more about A Clinical Observational Study of SARS-CoV-2 Specific CD8 T-Cell Responses to COVID-19 Vaccines in Humans

SARS-CoV-2 Infection Among Healthcare Workers

  • Read more about SARS-CoV-2 Infection Among Healthcare Workers

COVID-19 VACCINE SAFETY AND EFFECTIVENESS

  • Read more about COVID-19 VACCINE SAFETY AND EFFECTIVENESS

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 148
  • Page 149
  • Page 150
  • Page 151
  • Current page 152
  • Page 153
  • Page 154
  • Page 155
  • Page 156
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA